Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Institución de investigación sanitaria busca una compañía o start-up para desarrollar un proyecto del programa H2020 y diseñar herramientas nanobiotecnológicas modulares para detectar e interferir con la vía de señalización clave de la fibrosis cardíaca in vivo

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDES20161116001
Publicado:
28/11/2016
Caducidad:
22/11/2017
Resumen:
Un instituto español de investigación sanitaria está preparando una propuesta para la convocatoria H2020: NMBP-13-2017. El objetivo es desarrollar nuevos módulos estabilizadores de nanoclústeres fluorescentes para detección y visualización y módulos de reconocimiento de proteínas para objetivos específicos, detección e inhibición. El instituto busca socios con el fin de establecer acuerdos de investigación y diseñar herramientas nanobiotecnológicas modulares para detectar e interferir con la vía de señalización clave de la fibrosis cardíaca in vivo. La fecha límite de la convocatoria es el 19 de enero de 2017 y el plazo para presentar expresiones de interés finaliza el 12 de diciembre de 2016.

Details

Tittle:
Health Research Institute is looking for a partner (company or startup) to develop a project H2020 to designed modular nanobiotechnological tools to detect and interfere with the key signaling pathway of heart fibrosis in vivo
Summary:
A Spanish Health Research Institute is working on a proposal under H2020: NMBP-13-2017. It is looking for partners under a research cooperation agreement to designed modular nanobiotechnological tools to detect and interfere with the key signaling pathway of heart fibrosis in vivo. The project aims to develop new biotechnological fluorescent nanocluster stabilizing modules for detection and imaging to target a molecule recently involved in the progression of pathologycal fibrosis.
Description:
A Spanish Health Research Institute working in the field of biomedical sciences for improving patient care is looking for companies or startups to develop a project H2020 under a research cooperation agreement.
This project aims to develop new biotechnological tools for relevant applications in biomedicine by linking the expertise of groups from molecular biotechnology, molecular mechanisms of disease, small companies and hospitals for clinical application.Thus, it is clearly oriented to the Health Challenge.
From the protein engineering and biotechnology perspective,the project aims to exploit the potential of modular repeat protein-based structures to design tailored tools by the combination of functionalities. For this purpose, the Research Institute aims to design and rationally assemble a variety of functional structures using simple building blocks with specified properties. Mostly two types of modules will be developed based on the same protein unit:
1. Fluorescent nanocluster stabilizing modules for detection and imaging;
2.Protein recognition modules for specific targeting, detection,and inhibition.
Since the modules are based on the same structural scaffold the R-Y-D Institution hypothesizes that they can be fused into single proteins to form multifunctional molecular tools. Second generation designs will consider the coupling between the different functionalities, i.e.the ligand recognition and the fluorescent signal, to produce specific sensors for in vitro and in vivo tracking. Finally, the Research Institute will implement these tools into solid materials and combine them with advanced optical sensing technologies,for ex-vivo detection platforms.
From the prespective of the molecular mechanisms of cardiac fibrosis, the project aims to unravel key elements and presents novel therapeutic alternatives and detection tools. For this purpose, the Health Research Institute aims to target a molecule recently involved in the progression of disease. A disease-like pathological remodeling is present on hearts that had suffered a cardiac injury, most of them showing uncontrolled fibrotic events with an excess of extracellular matrix accumulation that can cause heart failure in the long term. The strategies are focused on reducing the pathological heart remodeling by the use of anti-fibrotic molecules. This could be extent to other fibrotic deseases. Strategies to block directly the main pro-fibrotic molecule (TGFß) cause important side effects that lead to life threatening complications. New tools to develop active anti-fibrotic drugs would be one step toward the absence of anti-fibrotic treatments. Alternative solutions could implicate heat shock protein 90 (Hsp90) which stabilizes TGFß receptor TGFßRI. Inhibition of Hsp90 causes TGFßRI destabilization without altering TGFß molecule,and leads to loss of function of TGFß cascade and reduction of collagen. The Health Research Institute pursues to get the noninvasive detection of human fibrotic damage at smaller scale with mice-adapted models and using Hsp90 KO mice together with promising anti-fibrotic molecule with the possibility of generating a biomarker for fibrotic events and procede to the translation into clinic. The global aim is the generation of biotechnological tools that target a key component of the disease reducing and detecting the degree of pathological fibrosis. This objective can only be tackled in a multidisciplinary way, as presented in this proposal, including the design of new multifunctional tools, the identification and understanding of key pathways related to disease, and the proof of concept application of the tools to target those pathways, including the inhibition and detection in vitro, in vivo and ex-vivo.

H2020 call: NMBP-13-2017 Cross-cutting KETs for diagnostics at the point-of-care.
Call deadline: 19/1/2017
Deadline for EoIs: 12/12/2016
Stage of Development:
Proposal under development

Partner sought

Partner Sought:
The Health Research Institute is looking for: - Start up 1: Large scale production of the different biomolecule formulations. Big scale production of functional structures based proteins. The project aims to use multifunctional proteins as tools for specific targeting, detection, and inhibition of specific dissease related pathways. The protein based furmulations will be hybrid by combining protin recongnition moieties with nanoelements. The required tasks will be to set up an up scaled production of the technology developed, which will include recombinant protein expression and post nanoconjugation. - Start up 2: Production a detection device for biomarkers of fibrosis in blood samples. We aim to implement a technology based on bioactive materials for the detection fibrosis biomarkers. We are looking for a company that could implement in a microfluidic device or design a Point of Care diagnosis device based on the technology developed by an academic group. The detection is based on a biomaterial made of proteins that encode specific recognition properties, which will be link to an optical detection.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
R-Y-D Institution
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
Spanish

Dissemination

Programme-call